NMIS Nuclear Medicine Software and Nuclear Medicine Information System Cost, NMIS vs BioDose, IBC and Optility

The short answer: a nuclear medicine information system is the hot lab's record of custody. It logs every radiopharmaceutical dose from the moment it arrives through assay, administration, residual and decay-in-storage, holds the dose calibrator, wipe test and survey records alongside, and prints the reports an NRC or agreement-state inspector opens first. In the United States the market is effectively three products: NMIS and BioDose, both now owned by Mirion after its 2023 purchase of ec2 Software Solutions; Comecer's IBC; and Mirion's older Optility line, which Mirion's own listing now describes as being replaced by the ec2 products. Federal contract awards put a site license and support at a median of $17,580, with 45 of 67 awards between $10,000 and $50,000 and an enterprise deployment at about $160,000 to $170,000.

Prices below are prime contract awards from USAspending.gov retrieved on September 17, 2026, with every recipient name and award description read before it was counted. Ownership facts are from Mirion Technologies' Q3 2023 results release and GE HealthCare's 2024 quarterly filing. Regulatory references are to 10 CFR Part 35.

What does NMIS stand for?

NMIS stands for Nuclear Medicine Information System. Generically it means any department management system for a nuclear medicine service, and specifically it is the name of the product created in 1985 that ec2 Software Solutions sold alongside BioDose after the two merged in 2011, and which Mirion Technologies acquired on November 1, 2023. The two meanings get mixed up in procurement documents. When a VA solicitation says "NMIS software", it usually means the product, and the award history below reflects that.

It is not an image system. An NMIS does not display, process or store PET or SPECT images, and it has no FDA clearance because it does not need one. The reading and quantification layer is a separate purchase, compared vendor by vendor on the nuclear medicine software page.

What does a nuclear medicine information system actually do?

It keeps the chain of custody that 10 CFR Part 35 obliges a licensee to be able to reconstruct. The rule requires that the activity of each dosage be determined and recorded before administration, that surveys and dose calibrator checks be performed and recorded, and that material held for decay-in-storage be surveyed before disposal, with records kept for three years. None of that requires software. All of it becomes unmanageable on paper at the volume of a department running a PET/CT and two gamma cameras.

The interface row decides how much the system is worth. Without the calibrator link, a technologist reads the activity off the instrument and types it in, which is the step inspectors find errors in. Without the HL7 link, patient demographics are keyed twice and the exam record in the radiology information system and the dose record in the NMIS drift apart. Both interfaces are priced separately in the federal record: one VA site paid $15,338 for an NMIS custom HL7 interface in May 2025, and a one-day onsite training visit for a custom network interface cost $18,275 at another VA site in 2014.

NMIS vs BioDose vs IBC vs Optility

The practical consequence of the 2023 acquisition is that a United States buyer is choosing among three products from one company plus one from an Italian hardware maker. That is not a criticism of Mirion, which also owns Capintec, the dose calibrator most of these systems interface to. It does mean the competitive quote you use to negotiate is harder to find, and that the honest lever is scope rather than vendor: the interface lines, the number of workstations, and the support term.

How much does a nuclear medicine information system cost?

A site license with support has a median federal award of $17,580 across 67 NMIS and BioDose awards from 2007 to 2026, after excluding label paper, parts and anything under $1,000. Forty-five of the 67 fall between $10,000 and $50,000. Since 2023 the median has moved up to $24,518 across 18 awards. The enterprise tier is a different animal: $169,479 for a VISN-wide BioDose deployment in September 2023 and $162,597 for a BioDose Enterprise upgrade in May 2026.

Two things about that record are worth knowing before you take a quote into a budget meeting. First, the support line is small in absolute terms but it is where the price moves after year one, so ask for the uplift clause; the same applies across the category and is covered in the radiology software contract terms worth negotiating. Second, almost every award is to a VA facility, and VA pricing runs through schedule contracts that a community hospital does not get automatically. Treat these figures as the floor of the negotiating range rather than the ceiling. For how the category sits against RIS, PACS and dose monitoring spending, radiology software pricing lays the federal records out side by side.

Do I need an NMIS for NRC compliance?

No regulation names one. 10 CFR Part 35 requires the records, not the software, and a small clinic doing a handful of thyroid uptakes a week can keep them in a bound logbook and pass inspection. The system earns its price at the point where the department cannot answer an inspector's question from memory: which patient received the dose drawn from a specific vial on a specific morning, what its residual was, and when it cleared decay-in-storage. That is a records query, and a logbook answers it slowly and a database answers it instantly. The productivity reports most systems generate, doses per technologist, referrals per physician, are a secondary benefit that departments end up using to justify staffing.

There is also a money reason that has nothing to do with the NRC. Unit doses are bought from a radiopharmacy at a price per dose, and the receiving record in the NMIS is the only independent evidence of what was actually delivered and when. Departments that match each delivered dose against the purchase order before the radiopharmacy invoice is paid find the short shipments and the doses that arrived after their calibration time; departments that do not simply pay the invoice.

Is an NMIS the same as dose monitoring software?

No, and the two are confused often enough to waste a procurement cycle. Dose monitoring software collects the radiation dose delivered to patients by CT and fluoroscopy equipment, reads the DICOM dose report the scanner emits, and benchmarks protocols. An NMIS tracks the activity of radiopharmaceuticals administered in nuclear medicine and the department's radioactive materials licence obligations. The CT half of a PET/CT does fall under the first category, and a department that runs hybrid imaging will end up with both systems; radiation dose monitoring software compares that category on its own terms.

What the NMIS does not do, and where the department's time actually goes

The information system closes the custody record and the processing workstation produces the measurements. Neither produces the report, and in a nuclear medicine service the report is the long pole. A whole-body PET/CT read in an oncology practice carries a measurement table against the prior study, a response assessment and a diagnostic CT read that often comes from a different radiologist than the physician who read the functional data. Most groups still dictate that from a blank page, and the variation between readers is where addenda come from.

Radiological.ai is not a nuclear medicine information system and does not track radiopharmaceuticals, and it does not process or quantify PET or SPECT data. It reads X-ray, CT and MRI. Where it fits a hybrid imaging department is the CT component of the PET/CT, which it screens for suspected findings and prioritizes on the worklist like any other CT, and the report itself, which it drafts into the department's own structured reporting template so the measurement table, the comparison fields and the impression sit in the same place on every study. The physician enters the functional interpretation and reviews, edits and signs every report.